Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EPS (Weighted Average and Diluted) (2018 - 2025)

Fortress Biotech has reported EPS (Weighted Average and Diluted) over the past 8 years, most recently at -$0.21 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at -$0.21 for Q4 2025, up 19.23% from a year ago — trailing twelve months through Dec 2025 was -$0.13 (up 95.34% YoY), and the annual figure for FY2025 was -$0.07, up 97.4%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.21 at Fortress Biotech, down from $0.11 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for FBIO hit a ceiling of $0.45 in Q2 2025 and a floor of -$4.82 in Q4 2022.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was -$0.32 (2021), compared with a mean of -$0.92.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 1480.77% in 2022 and later surged 161.64% in 2025.
  • Fortress Biotech's EPS (Weighted Average and Diluted) stood at -$0.38 in 2021, then plummeted by 1168.42% to -$4.82 in 2022, then surged by 89.0% to -$0.53 in 2023, then surged by 50.94% to -$0.26 in 2024, then grew by 19.23% to -$0.21 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were -$0.21 (Q4 2025), $0.11 (Q3 2025), and $0.45 (Q2 2025) per Business Quant data.